This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanyang Technological University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Laximikant Khanolkar: Innovator in Medical Devices
Introduction
Laximikant Khanolkar is a notable inventor based in Singapore, recognized for his contributions to the field of medical devices. He has developed innovative solutions aimed at addressing anatomical defects in tissue, showcasing his expertise and commitment to advancing healthcare technology.
Latest Patents
Khanolkar holds a patent for an occlusion device designed for closing anatomical defects. This device features a conduit that connects openings in two different tissues. The occlusion device includes a scaffold with a proximal support structure and a distal support structure, both equipped with arms that provide anchorage within the tissue. The scaffold is primarily made of biodegradable polymers, specifically polycaprolactone (PCL) and poly-(D,L-lactide-co-caprolactone) (PLC), ensuring that the device is both effective and environmentally friendly.
Career Highlights
Khanolkar is affiliated with Nanyang Technological University, where he continues to engage in research and development in the medical field. His work emphasizes the importance of innovation in creating solutions that can significantly improve patient outcomes.
Collaborations
Khanolkar has collaborated with esteemed colleagues such as Subramanian Venkatraman and Yin Chiang Freddy Boey. These partnerships reflect a commitment to teamwork and the sharing of knowledge in the pursuit of groundbreaking medical advancements.
Conclusion
Laximikant Khanolkar's contributions to medical device innovation highlight the critical role of inventors in enhancing healthcare solutions. His patented occlusion device exemplifies the intersection of technology and medicine, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
